NasdaqCM - Nasdaq Real Time Price • USD
Bio-Path Holdings, Inc. (BPTH)
At close: April 25 at 4:00 PM EDT
Pre-Market: 8:27 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
15,843.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Operating Income
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Net Non Operating Interest Income Expense
36.0000
36.0000
33.0000
3.0000
26.0000
Other Income Expense
-271.0000
-271.0000
--
--
--
Pretax Income
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Net Income Common Stockholders
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Diluted NI Available to Com Stockholders
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Basic EPS
-40.00
-33.63
-38.12
-31.00
-56.60
Diluted EPS
-40.00
-33.63
-38.12
-31.00
-56.60
Basic Average Shares
420.2380
478.0000
364.0000
336.2500
192.3500
Diluted Average Shares
420.2380
478.0000
364.0000
336.2500
192.3500
Total Operating Income as Reported
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Total Expenses
15,843.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Net Income from Continuing & Discontinued Operation
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Normalized Income
-15,807.0000
-15,807.0000
-13,868.0000
-10,440.0000
-10,882.0000
Interest Income
36.0000
36.0000
33.0000
3.0000
26.0000
Net Interest Income
36.0000
36.0000
33.0000
3.0000
26.0000
EBIT
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
EBITDA
-15,665.0000
-15,665.0000
-13,723.0000
-10,282.0000
-10,757.0000
Reconciled Depreciation
178.0000
178.0000
178.0000
161.0000
151.0000
Net Income from Continuing Operation Net Minority Interest
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Total Unusual Items Excluding Goodwill
-271.0000
-271.0000
--
--
--
Total Unusual Items
-271.0000
-271.0000
--
--
--
Normalized EBITDA
-15,394.0000
-15,394.0000
-13,723.0000
-10,282.0000
-10,757.0000
12/31/2020 - 3/4/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MLEC Moolec Science SA
1.4200
-2.74%
NKGN NKGen Biotech, Inc.
1.9800
+15.79%
PALI Palisade Bio, Inc.
6.23
-1.89%
PCSA Processa Pharmaceuticals, Inc.
2.4300
+50.00%
ABVC ABVC BioPharma, Inc.
1.5900
+7.43%
CDTX Cidara Therapeutics, Inc.
13.00
+5.78%
IBRX ImmunityBio, Inc.
5.11
+6.02%
CADL Candel Therapeutics, Inc.
6.43
+6.28%
JAGX Jaguar Health, Inc.
0.1700
+0.06%
LGVN Longeveron Inc.
1.6700
-2.91%